Mindfulness meditation and psychedelics: potential synergies and commonalities
Open accessThe DOI matches its Crossref record; 116 of the 122 references it cites were found in a registry or an index; 66 of the 107 sources its claims cite were checked for support.
Abstract
There has been increasing scientific and clinical interest in studying psychedelic and meditation-based interventions in recent years, both in the context of improving mental health and as tools for understanding the mind. Several authors suggest neurophysiological and phenomenological parallels and overlaps between psychedelic and meditative states and suggest synergistic effects of both methods. Both psychedelic-assisted therapy and meditation training in the form of mindfulness-based interventions have been experimentally validated with moderate to large effects as alternative treatments for a variety of mental health problems, including depression, addictions, and anxiety disorders. Both demonstrated significant post-acute and long-term decreases in clinical symptoms and enhancements in well-being in healthy participants, in addition. Postulated shared salutogenic mechanisms, include, among others the ability to alter self-consciousness, present-moment awareness and antidepressant action via corresponding neuromodulatory effects. These shared mechanisms between mindfulness training and psychedelic intervention have led to scientists theorizing, and recently demonstrating, positive synergistic effects when both are used in combination. Research findings suggest that these two approaches can complement each other, enhancing the positive effects of both interventions. However, more theoretical accounts and methodologically sound research are needed before they can be extended into clinical practice. The current review aims to discuss the theoretical rationale of combining psychedelics with mindfulness training, including the predictive coding framework as well as research findings regarding synergies and commonalities between mindfulness training and psychedelic intervention. In addition, suggestions how to combine the two modalities are provided. © 2023, The Author(s).
Overview
CoChat Summary
## TL;DR
This paper is a narrative review arguing that mindfulness meditation and psychedelic interventions may be complementary, with overlapping effects on self-related processing, emotion regulation, psychological flexibility, and mental health. It concludes that the combination is promising but that stronger, more controlled research is needed before clinical use can be confidently extended.
## Key findings
- The paper states that both psychedelic-assisted therapy and mindfulness-based interventions have been “experimentally validated with moderate to large effects” for conditions including depression, addictions, and anxiety disorders.
- It reports that a randomized study of 38 participants found that high-dose psilocybin combined with high-support spiritual practice produced more immediate and long-lasting effects on measures including interpersonal closeness, gratitude, and life meaning/purpose, with outcomes linked to psilocybin-occasioned mystical-type experience and engagement with meditation practices.
- It cites another study of people with long-term mindfulness meditation experience during a 5-day Zen meditation retreat in which psilocybin’s effects on self-referential brain regions (the default mode network) correlated with subjective ego dissolution, and 4 months of follow-up showed bigger favorable gains in psychosocial functioning than placebo.
- The review argues that combining the two approaches may help with decentering, emotion regulation, psychological flexibility, prosociality, and psychopathology reduction, and that mindfulness may enhance psychedelic-induced ego dissolution while psychedelics may deepen meditation practice.
## Methods
- Narrative review / conceptual synthesis of the literature on mindfulness meditation and psychedelic interventions; no original empirical sample was collected by the authors.
- Draws on prior studies, reviews, meta-analyses, expert opinions, and a small number of combined-methodology trials, including the 38-participant randomized trial and a 5-day Zen meditation retreat study.
- Main analysis is thematic: it compares the two approaches across phenomenology, altered states of consciousness, neurobiology, prosociality, decentering, emotion regulation, psychological flexibility, psychopathology reduction, combined-method studies, and a predictive coding framework.
## Limitations
- The paper states that more “theoretical accounts and methodologically sound research are needed” before the combination can be extended into clinical practice.
- It explicitly notes that research on the synergistic effects suffers from methodological limitations, and that both meditation and psychedelic fields are marked by strong bias effects, which may overestimate benefits; it calls for larger sample sizes, independent raters, active placebos, and replication studies.
- Evident from the text: the article is a review, so its conclusions depend on heterogeneous prior studies rather than a single controlled dataset; the paper itself also acknowledges that the available evidence is still evolving and that not everyone may benefit equally.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
51 Valid · 7 Not valid · 22 Not checked · 30 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Such disruption is believed to be associated with the experience of ego dissolution [71].”
§ Mindfulness meditation and psychedelics: potential synergies and commonalities > Neurobiology of psychedelics and mindfulness meditation Classic psychedelics like LSD, psilocybin, mescaline, and DMT primarily act as agonists to the serotonin 5-HT2A receptor, and considering the extensive range targeted by the serotonergic system, they have a significant effect on the brain's neurochemistry [61]. The high presence of the 5-HT2A receptor in regions like the prefrontal cortex—integral for higher-order cognitive functions—underscores the transformative nature of these compounds on cognition and perception [62, 63]. The other explanation of psychedelics' ability to facilitate altered states of consciousness characterized by heightened introspection and diminished ego boundaries is their influence on 5-HT1A [64] and 5-HT2B [65], and interacting with the dopaminergic [66] and glutamatergic systems [67]. Interestingly, the salience network, which determines which stimuli warrant our focus, has also been investigated as a neural correlate of self [68, 69]. Research indicates that psychedelics disrupt the functioning of the salience network, potentially leading to altered perceptions of self and world [70]. Such disruption is believed to be associated with the experience of ego dissolution [71]. Complementing this, there's also a notable link between psychedelics and the induction of profound, mystical experiences (which are usually marked by ego dissolution), which are said to be characterized by heightened brain entropy [50]. Brain entropy in the realm of neuroscience serves as an indicator of a system's uncertainty. The higher entropy means more complex, diverse, and unpredictable neural activity [50]. In the context of the brain, this denotes a blend of disorganization paving the way for a more diverse range of dynamic neural states [72]. Meditation, particularly mindfulness practices, has garnered significant attention for its profound neurobiological effects as well. Similarly to the mechanism of default mode network DMN influenced by psychedelics, mindfulness meditation decreases DMN activity which leads to changes in the precision-weighting of beliefs and attention [41]. MM was also found to reduce the activity of the midline prefrontal cortex and posterior cingulate cortex, which are integral parts of the DMN, suggesting that mindfulness training can alter self-awareness pathways and promote present-moment consciousness [73]. Beyond these neural circuits, MM encourages widespread neuroplastic changes. For example, comparative studies between meditators and non-meditators have revealed differences in brain connectivity, activation patterns, and both gray and white matter density [74]. In addition, the thalamus, a key region in sensory gating, is also involved in the meditative states [36, 41].
What the sources say
- Disputedcites [71] Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci U S A. 2016;113(17):4853–8. sourceExperimental — accuracy not yet measured
The Results (p. 3) identify reduced segregation between the default mode and salience networks under LSD, but report that reduced network segregation did not correlate with ego-dissolution. They instead find a significant correlation with default mode network disintegration; correlations with the integrity of the other 11 networks were not significant. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Several studies [6, 7] and expert opinions [8] suggest that combining these two approaches may enhance therapeutic outcomes.”
§ Mindfulness meditation and psychedelics: potential synergies and commonalities > Introduction
What the sources say
- Could not verifycites [6] Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181–97. https://doi.org/10.1177/0269881116675513. (PMID:27909165;PMCID:PMC5367557). sourceExperimental — accuracy not yet measured
The Methods (Interventions; page unavailable) describe psilocybin sessions with supportive monitors; meditation appears only as an example of monitors’ prior experience, not as a participant intervention. The Results and Discussion report therapeutic improvements associated with psilocybin, but do not assess whether combining it with mindfulness meditation enhances outcomes. Searched for mindfulness meditation, meditation, and psychological support. (LLM, conf=0.76)
- Supportedcites [7] Smigielski L, Kometer M, Scheidegger M, Krähenmann R, Huber T, Vollenweider FX. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. Sci Rep. 2019;9:14914. source
The Discussion says the combination of mindfulness training and psilocybin may improve psychological outcomes and has potential to improve well-being and health in therapeutic settings. That supports the citing sentence’s hedged claim, although the study itself involved experienced meditators at a retreat rather than patients receiving therapy. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [8] Payne JE, Chambers R, Liknaitzky P. Combining psychedelic and mindfulness interventions: synergies to inform clinical practice. ACS Pharmacol Transl Sci. 2021;4(2):416–23. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Classic psychedelics, such as synthetic LSD and psilocybin, which is found in certain mushrooms, have shown promise as aids in psychotherapy e.g., for mood disorders and substance dependence [1, 5, 33].”
§ Mindfulness meditation and psychedelics: potential synergies and commonalities > Psychedelics and psychedelic interventions Psychedelics as a class of psychoactive substances, which induce intense and transformative experiences that might provide rapid insights, potentially accelerating some of the benefits derived from mindfulness practices [28]. Psychedelics themselves induce altered states of consciousness, characterized by profound perceptual, cognitive, and emotional experiences [3]. The term, however, is frequently utilized in a sweeping manner to encompass diverse categories of hallucinogens related to psychedelics. To prevent any potential numerical errors, the term "classic psychedelics'' is used, referring to the category of substances that bind to serotonin receptors in the brain, with 5HT2A receptor selectivity [29]. This group includes mescaline, Lysergic Acid Diethylamide (LSD), and naturally occurring alkaloids, such as 4-phosphoriloxy-N,N-dimethyltryptamine (psilocybin, present in hundreds of Psilocybe mushroom species), ayahuasca, and DMT, among others [30]. Additionally, there are other types of psychedelics, such as 2-(2-Chlorophenyl)-2-(methylamino) ketamine and 3,4-MethylenedioxyMethamphetamine (MDMA). Ketamine is a dissociative psychedelic, which acts as NMDAR (N-methyl-D-aspartate receptor) antagonists, effectively engaging the glutamatergic system [31]. MDMA is known as “empathogenic psychedelics”, or “entactogen”, acting primarily by increasing the release of serotonin, dopamine, and norepinephrine and inhibiting their reuptake [32]. As previously noted, mindfulness practices facilitate behavioral change by enabling individuals to identify triggers and habitual responses, whereas psychedelic therapy can amplify this awareness, resulting in even deeper behavioral transformations [33]. Furthermore, while the effects of psychedelics are not permanent, they can produce long-lasting changes from even a single session, potentially complementing the regular practice required by mindfulness [7]. The potential therapeutic applications of psychedelics, often referred to as psychedelic interventions or psychedelic-assisted therapy (PAT), have opened new avenues for addressing mental health conditions. Classic psychedelics, such as synthetic LSD and psilocybin, which is found in certain mushrooms, have shown promise as aids in psychotherapy e.g., for mood disorders and substance dependence [1, 5, 33]. Psychedelic-assisted psychotherapy involves guided sessions where individuals receive a controlled dose of a psychedelic under the supervision of trained therapists. This approach aims to enhance emotional processing, encourage introspection, and facilitate breakthroughs in therapy [34].
What the sources say
- Supportedcites [1] Carhart-Harris RL, Goodwin GM. The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology. 2017;42(11):2105–13. source
The paper’s introductory summary (page not specified in our copy) describes LSD as an aid to psychotherapy that showed initial promise for mood disorders and alcohol dependence. “The Present Revival” also reports preliminary positive findings for psilocybin in depression, alcohol dependence, and tobacco addiction, supporting the broader reference to substance dependence. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [5] Muttoni S, Ardissino M, John C. Classical psychedelics for the treatment of depression and anxiety: a systematic review. J Affect Disord. 2019;258:11–24. source
- Partly supportedcites [33] Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abuse. 2017;43(1):55–60. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says the smoking-cessation findings, together with evidence on alcoholism and alcohol dependence, suggest therapeutic potential for psychedelics in structured treatment of substance use disorders. The paper does not establish the claimed promise for treating mood disorders; its references to mood concern measured changes, not mood-disorder treatment. (LLM, conf=0.88)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Several meta-analyses of iMBI studies demonstrated that iMBIs, much like traditional MBI, effectively reduce stress and alleviate emotional distress, including depressive and anxiety symptoms [20, 21].”
§ Mindfulness meditation and psychedelics: potential synergies and commonalities > Mindfulness meditation and mindfulness-based interventions Mindfulness, rooted in Eastern contemplative traditions, has gained significant recognition in Western psychology and healthcare in the recent 2 decades. Mindfulness meditation usually involves directing one's attention to the breath, bodily sensations, thoughts, and emotions, promoting a sense of presence. One of the most popular definitions describes mindfulness as the awareness that emerges when deliberately and nonjudgmentally paying attention to the present moment experience [12]. Originally developed within Buddhist and other wisdom traditions to alleviate mental suffering and gain insights, mindfulness has been integrated into the Western mainstream of medicine under the umbrella term mindfulness-based interventions (MBIs). Among MBIs, there are two main mindfulness training: mindfulness-based stress reduction (MBSR) developed by the pioneer of mindfulness John Kabat-Zinn in 1978, and mindfulness-based cognitive therapy (MBCT) which has gained more empirical evidence of effectiveness in mental disorders. MBIs encompass structured programs that incorporate mindfulness practices within various contexts including clinical settings, education, and workplace wellness programs. Studies show that MBIs can enhance emotional regulation, attentional control, and self-awareness [13], inferring positive effects on well-being, alleviation of anxiety, depression, and stress symptoms [14]. The benefits of MM extend beyond psychological well-being, however. Mindfulness meditation has been associated with improved physical health outcomes and pain management [14]. Mindfulness-based interventions have also shown promise in behavior change and addiction treatment [15]. They help develop a greater awareness of addiction triggers and automatic reactions, enabling practitioners to respond more skillfully to challenging situations [15]. Beyond that, this broader awareness can lead to healthier choices and reduced impulsivity.
What the sources say
- Supportedcites [20] Spijkerman MP, Pots WT, Bohlmeijer ET. Effectiveness of online mindfulness-based interventions in improving mental health: a review and meta-analysis of randomised controlled trials. Clin Psychol Rev. 2016;45:102–14. source
The abstract reports significant benefits of online mindfulness-based interventions for depression, anxiety, and stress, with the largest effect for stress. Section 4.1 also describes the stress effect as comparable to that found for traditional mindfulness-based interventions. (LLM, conf=0.93)
- Supportedcites [21] Sommers-Spijkerman M, Austin J, Bohlmeijer E, Pots W. New evidence in the booming field of online mindfulness: An updated meta-analysis of randomized controlled trials. JMIR Mental Health. 2021;8(7): e28168. source
The Discussion (Principal Findings; page not provided) reports that online mindfulness-based programs reduced depression, anxiety, and stress symptoms. The Introduction (Background; page not provided) also reports reductions in all three outcomes in an earlier meta-analysis. The cited paper therefore supports the claim about internet-based interventions; it does not need to establish that they are equally effective as traditional interventions. (LLM, conf=0.92)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As previously noted, mindfulness practices facilitate behavioral change by enabling individuals to identify triggers and habitual responses, whereas psychedelic therapy can amplify this awareness, resulting in even deeper behavioral transformations [33].”
§ Mindfulness meditation and psychedelics: potential synergies and commonalities > Psychedelics and psychedelic interventions Psychedelics as a class of psychoactive substances, which induce intense and transformative experiences that might provide rapid insights, potentially accelerating some of the benefits derived from mindfulness practices [28]. Psychedelics themselves induce altered states of consciousness, characterized by profound perceptual, cognitive, and emotional experiences [3]. The term, however, is frequently utilized in a sweeping manner to encompass diverse categories of hallucinogens related to psychedelics. To prevent any potential numerical errors, the term "classic psychedelics'' is used, referring to the category of substances that bind to serotonin receptors in the brain, with 5HT2A receptor selectivity [29]. This group includes mescaline, Lysergic Acid Diethylamide (LSD), and naturally occurring alkaloids, such as 4-phosphoriloxy-N,N-dimethyltryptamine (psilocybin, present in hundreds of Psilocybe mushroom species), ayahuasca, and DMT, among others [30]. Additionally, there are other types of psychedelics, such as 2-(2-Chlorophenyl)-2-(methylamino) ketamine and 3,4-MethylenedioxyMethamphetamine (MDMA). Ketamine is a dissociative psychedelic, which acts as NMDAR (N-methyl-D-aspartate receptor) antagonists, effectively engaging the glutamatergic system [31]. MDMA is known as “empathogenic psychedelics”, or “entactogen”, acting primarily by increasing the release of serotonin, dopamine, and norepinephrine and inhibiting their reuptake [32]. As previously noted, mindfulness practices facilitate behavioral change by enabling individuals to identify triggers and habitual responses, whereas psychedelic therapy can amplify this awareness, resulting in even deeper behavioral transformations [33]. Furthermore, while the effects of psychedelics are not permanent, they can produce long-lasting changes from even a single session, potentially complementing the regular practice required by mindfulness [7]. The potential therapeutic applications of psychedelics, often referred to as psychedelic interventions or psychedelic-assisted therapy (PAT), have opened new avenues for addressing mental health conditions. Classic psychedelics, such as synthetic LSD and psilocybin, which is found in certain mushrooms, have shown promise as aids in psychotherapy e.g., for mood disorders and substance dependence [1, 5, 33]. Psychedelic-assisted psychotherapy involves guided sessions where individuals receive a controlled dose of a psychedelic under the supervision of trained therapists. This approach aims to enhance emotional processing, encourage introspection, and facilitate breakthroughs in therapy [34].
What the sources say
- Partly supportedcites [33] Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abuse. 2017;43(1):55–60. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports lasting psychological and behavioral shifts following psychedelic administration. It does not say that psychedelic therapy amplifies awareness of triggers or habitual responses, or compare the depth of those changes with mindfulness-based change. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
43 more claims · 20 with their cited sources checked
Create a free account to see all 110 claims and every source verdict.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 53
Citations
Cites
The Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
The free-energy principle: a unified brain theory?
Friston, K. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2787 · Cited by 8,120 · cited 2×
“…by making them less reactive to it and by improving the brain's ability to regulate stress-related processes, through its effect on the hypothalamic–pituitary–adrenal (HPA) axis, cortisol secretion [107, [99], and additionally reduction of pro-inflammatory cytokines, including IL-6 [107, 109].”
BackgroundHow do you feel — now? The anterior insula and human awareness
(Bud) Craig, A. D. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2555 · Cited by 6,657 · cited 1×
“Interestingly, the salience network, which determines which stimuli warrant our focus, has also been investigated as a neural correlate of self [68, 69].”
BackgroundKrystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · cited 1×
“Ketamine is a dissociative psychedelic, which acts as NMDAR (N-methyl-D-aspartate receptor) antagonists, effectively engaging the glutamatergic system [31].”
BackgroundHölzel, B. K., Lazar, S. W., Gard, T., Schuman-Olivier, Z., Vago, D. R., & Ott, U. (2011) · Perspectives on Psychological Science · doi:10.1177/1745691611419671 · Cited by 3,024 · cited 1×
“Studies show that MBIs can enhance emotional regulation, attentional control, and self-awareness [13], inferring positive effects on well-being, alleviation of anxiety, depression, and stress symptoms [14].”
BackgroundWherever you go, there you are: Mindfulness meditation in everyday life
Kwee, M. (1995) · Behaviour Research and Therapy · doi:10.1016/0005-7967(95)90133-7 · Cited by 2,896 · cited 1×
“One of the most popular definitions describes mindfulness as the awareness that emerges when deliberately and nonjudgmentally paying attention to the present moment experience [12].”
BackgroundThe Neuroscience of Mindfulness Meditation
Tang, Y.-Y., Hölzel, B. K., & Posner, M. I. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn3916 · Cited by 2,889 · cited 2×
“MM was also found to reduce the activity of the midline prefrontal cortex and posterior cingulate cortex, which are integral parts of the DMN, suggesting that mindfulness training can alter self-awareness pathways and promote present-moment consciousness [73].”
BackgroundGriffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 4×
“The results showed, that high-dose psilocybin combined with HS spiritual practices led to more immediate and long-lasting effects at a wide range of measures including interpersonal closeness, gratitude, and life meaning/purpose [6].”
BackgroundMethodResultInfluentialAndrews‐Hanna, J. R., Smallwood, J., & Spreng, R. N. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12360 · Cited by 2,102
Interoceptive inference, emotion, and the embodied self
Seth, A. K. (2013) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2013.09.007 · Cited by 1,816 · cited 1×
“Interestingly, the salience network, which determines which stimuli warrant our focus, has also been investigated as a neural correlate of self [68, 69].”
Background
Research works printed but not linked: 4
- Grinspoon L, Doblin R. Psychedelics as catalysts of insight-oriented psychotherapy. Soc Res. 2001;68(3):677–95.
- Wardeszkiewicz J, Holas P. Internet-delivered modified Mindfulness-Based Cognitive Therapy (iMBCT) intervention for perceived stress and emotional distress: a pilot RCT study. Psych Res. (under review).
- Visted E, Vøllestad J, Nielsen MB, Schanche E. Emotion regulation in current and remitted depression: a systematic review and meta-analysis. Front Psychol. 2015;6:1892.
- Butler M, Jelen L, Rucker J. Expectancy in placebo-controlled trials of psychedelics: if so, so what? Psychopharmacology. 2022;239(10):3047–55. · DOI · Paper page
Cited by
Development of a digital intervention for psychedelic preparation (DIPP)
McAlpine, R. G., Sacchet, M. D., Simonsson, O., Khan, M. M., Krajnović, K., Morometescu, L., & Kamboj, S. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-54642-4 · Cited by 18
“In both studies, ‘Meditation’ was consistently identified as a valuable preparatory component for psychedelic experiences, which corresponds with previous research 95–98 .”
ResultUnderstanding the sense of self through robotics
Prescott, T. J., Vogeley, K. T., & Wykowska, A. (2024) · Science Robotics · doi:10.1126/scirobotics.adn2733 · Cited by 31
Walther, R. F. E., & van Schie, H. T. (2024) · Psychoactives · doi:10.3390/psychoactives3030026 · Cited by 22
Lewis, B. R., Hendrick, J., Byrne, K., Odette, M. M., Wu, C., & Garland, E. L. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004519 · Cited by 20
Mechanisms of psilocybin on the treatment of posttraumatic stress disorder
Choi, C. Q., Johnson, D. E., Chen-Li, D. C. J., & Rosenblat, J. D. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241286771 · Cited by 16
“Meditation and psilocybin exert similar effects on the body and can induce an altered state of consciousness or induce mystical experiences characterized by a sense of unity and interconnectedness (Holas and Kamińska, 2023).”
Metadata
- Authors
- Holas, P., & Kamińska, J.
- Affiliations
- University of Warsaw (PL)
- Corresponding author
- Holas, Paweł
- ORCID
- Holas, Paweł
- Venue
- Pharmacological Reports
- Published
- 2023-11-06
- Volume
- 75
- Issue
- 6
- Pages
- 1398-1409
- ISSN
- 1734-1140 (ISSN-L)
- 2299-5684
- PMC
- PMC10661803
- OpenAlex
- W4388418934
- Semantic Scholar
- e680031408ed301a896a8b52e71ae23f1d33913e
- Cited by
- 43
- References
- 122
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 9 · 2023: 3
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Pharmacological Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Uniwersytet Warszawski (PSP 501-D125-20-0004316)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- mindfulness meditation, psychedelics, psychedelic therapy, mindfulness-based interventions, synergistic effect, predictive coding, self-consciousness, present-moment awareness, antidepressant effects, depression, anxiety disorders, addiction, mental health, well-being
- MeSH terms
- Emotions, Hallucinogens, Humans, Meditation, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mindfulness meditation and psychedelics: potential synergies and commonalities. https://app.cochat.ai/papers/10.1007/s43440-023-00551-8
- The paper
- Holas, P., & Kamińska, J. (2023). Mindfulness meditation and psychedelics: potential synergies and commonalities. Pharmacological Reports. https://doi.org/10.1007/s43440-023-00551-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.